NCT07156149View on ClinicalTrials.gov

Fabhalta Capsules Specified Drug-use Survey

Not yet recruitingOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

September 30, 2025

Primary Completion Date

June 30, 2028

Study Completion Date

June 30, 2028

Conditions
C3 Glomerulopathy
Sponsors
All Listed Sponsors
lead

Novartis Pharmaceuticals

INDUSTRY